Systematic Review of Epigenetic Effects of Pharmacological Agents for Bipolar Disorders

Overview

Journal Brain Sci

Publisher MDPI

Date 2017 Nov 22

PMID 29156546

Citations 8

Authors

Laura E Lockwood

Nagy A Youssef

Affiliations

Soon will be listed here.

Abstract

Epigenetic effects of medications are an evolving field of medicine, and can change the landscape of drug development. The aim of this paper is to systematically review the literature of the relationship between common medications used for treatment of bipolar disorders and epigenetic modifications. MedLine/PubMed searches were performed based on pre-specified inclusion criteria from inception to November 2017. Six animal and human studies met the inclusion criteria. These studies examined the epigenetic changes in the main classes of medications that are used in bipolar disorders, namely mood stabilizers and antipsychotics. Although these initial studies have small to moderate sample size, they generally suggest an evolving and accumulating evidence of epigenetic changes that are associated with several of the medications that are used in bipolar I and II disorders. In this manuscript, we describe the specific epigenetic changes that are associated with the medications studied. Of the studies reviewed, five of the six studies revealed epigenetic changes associated with the use of mood stabilizers or antipsychotic medications. This review contributes to future research directions. Further understanding of the complexities of the epigenome and the untangling of the effects and contributions of disease states versus medications is crucial for the future of drug design and the development of new therapeutics. Epigenetic therapeutics hold great promise for complex disease treatment and personalized interventions, including psychiatric diseases.

Citing Articles

DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study.

Dubath C, Porcu E, Delacretaz A, Grosu C, Laaboub N, Piras M Clin Epigenetics. 2024; 16(1):36.

PMID: 38419113 PMC: 10903022. DOI: 10.1186/s13148-024-01648-4.

Potential Societal and Cultural Implications of Transgenerational Epigenetic Methylation of Trauma and PTSD: Pathology or Resilience?.

Youssef N Yale J Biol Med. 2022; 95(1):171-174.

PMID: 35370497 PMC: 8961703.

Biopsychosocial Factors during the Perinatal Period: Risks, Preventative Factors, and Implications for Healthcare Professionals.

Blount A, Adams C, Anderson-Berry A, Hanson C, Schneider K, Pendyala G Int J Environ Res Public Health. 2021; 18(15).

PMID: 34360498 PMC: 8346061. DOI: 10.3390/ijerph18158206.

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research.

Melas P, Scherma M, Fratta W, Cifani C, Fadda P Int J Mol Sci. 2021; 22(4).

PMID: 33668469 PMC: 7917759. DOI: 10.3390/ijms22041863.

Skeletal muscle DNA methylation modifications and psychopharmacologic treatment in bipolar disorder.

Burghardt K, Howlett B, Sanders E, Dass S, Msallaty Z, Mallisho A Eur Neuropsychopharmacol. 2019; 29(12):1365-1373.

PMID: 31635791 PMC: 6924624. DOI: 10.1016/j.euroneuro.2019.10.001.

References

Vieta E, Reinares M, Rosa A . Staging bipolar disorder. Neurotox Res. 2010; 19(2):279-85. DOI: 10.1007/s12640-010-9197-8. View

DellOsso B, DAddario C, Palazzo M, Benatti B, Camuri G, Galimberti D . Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients. J Affect Disord. 2014; 166:330-3. DOI: 10.1016/j.jad.2014.05.020. View

Goldberg A, Allis C, Bernstein E . Epigenetics: a landscape takes shape. Cell. 2007; 128(4):635-8. DOI: 10.1016/j.cell.2007.02.006. View

Soeiro-de-Souza M, Teixeira A, Mateo E, Zanetti M, Rodrigues F, de Paula V . Leukocyte telomerase activity and antidepressant efficacy in bipolar disorder. Eur Neuropsychopharmacol. 2014; 24(7):1139-43. DOI: 10.1016/j.euroneuro.2014.03.005. View

Riddihough G, Zahn L . Epigenetics. What is epigenetics? Introduction. Science. 2010; 330(6004):611. DOI: 10.1126/science.330.6004.611. View

Axelson D, Goldstein B, Goldstein T, Monk K, Yu H, Hickey M . Diagnostic Precursors to Bipolar Disorder in Offspring of Parents With Bipolar Disorder: A Longitudinal Study. Am J Psychiatry. 2015; 172(7):638-46. PMC: 4489996. DOI: 10.1176/appi.ajp.2014.14010035. View

Melka M, Castellani C, Laufer B, Rajakumar R, OReilly R, Singh S . Olanzapine induced DNA methylation changes support the dopamine hypothesis of psychosis. J Mol Psychiatry. 2014; 1(1):19. PMC: 4223857. DOI: 10.1186/2049-9256-1-19. View

Jones P, Issa J, Baylin S . Targeting the cancer epigenome for therapy. Nat Rev Genet. 2016; 17(10):630-41. DOI: 10.1038/nrg.2016.93. View

Azad M, Shoesmith W, Al Mamun M, Abdullah A, Naing D, Phanindranath M . Cardiovascular diseases among patients with schizophrenia. Asian J Psychiatr. 2016; 19:28-36. DOI: 10.1016/j.ajp.2015.11.012. View

10.

Zannas A, Provencal N, Binder E . Epigenetics of Posttraumatic Stress Disorder: Current Evidence, Challenges, and Future Directions. Biol Psychiatry. 2015; 78(5):327-35. DOI: 10.1016/j.biopsych.2015.04.003. View

11.

Lockwood L, Su S, Youssef N . The role of epigenetics in depression and suicide: A platform for gene-environment interactions. Psychiatry Res. 2015; 228(3):235-42. DOI: 10.1016/j.psychres.2015.05.071. View

12.

Mantzoros C . The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med. 1999; 130(8):671-80. DOI: 10.7326/0003-4819-130-8-199904200-00014. View

13.

Mostafavi Abdolmaleky H, Zhou J, Thiagalingam S . An update on the epigenetics of psychotic diseases and autism. Epigenomics. 2015; 7(3):427-49. DOI: 10.2217/epi.14.85. View

14.

Melka M, Laufer B, McDonald P, Castellani C, Rajakumar N, OReilly R . The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum. Clin Epigenetics. 2014; 6(1):1. PMC: 3895844. DOI: 10.1186/1868-7083-6-1. View

15.

Peedicayil J . Epigenetic Drugs for Multiple Sclerosis. Curr Neuropharmacol. 2016; 14(1):3-9. PMC: 4787283. DOI: 10.2174/1570159x13666150211001600. View

16.

Lardenoije R, Iatrou A, Kenis G, Kompotis K, Steinbusch H, Mastroeni D . The epigenetics of aging and neurodegeneration. Prog Neurobiol. 2015; 131:21-64. PMC: 6477921. DOI: 10.1016/j.pneurobio.2015.05.002. View

17.

Lee R, Pirooznia M, Guintivano J, Ly M, Ewald E, Tamashiro K . Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene. Transl Psychiatry. 2015; 5:e600. PMC: 5068731. DOI: 10.1038/tp.2015.90. View

18.

Houtepen L, van Bergen A, Vinkers C, Boks M . DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder. Epigenomics. 2016; 8(2):197-208. DOI: 10.2217/epi.15.98. View

19.

Berk M, Post R, Ratheesh A, Gliddon E, Singh A, Vieta E . Staging in bipolar disorder: from theoretical framework to clinical utility. World Psychiatry. 2017; 16(3):236-244. PMC: 5608827. DOI: 10.1002/wps.20441. View